Board of Directors

Herbert J. Conrad Chairman
US President of Roche Pharmaceuticals (retired)

Thomas Dyrberg MD
Novo A/S

Patrick J. Fortune PhD
Boston Millennia Partners

Lutz Giebel PhD
SV Life Sciences

Carl L. Gordon PhD, CFA
OrbiMed Advisors, LLC

Bruce Peacock
SV Life Sciences

William J. Polvino, MD
President & CEO of Sapphire Therapeutics